• NatureSynthetic

Associated products


Our Abpromise guarantee covers the use of ab39353 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-Plzf antibody (ab39354)

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • AI467657
    • lu
    • PLZF
    • Promyelocytic leukemia zinc finger protein
    • ZBT16_HUMAN
    • ZBTB16
    • Zfp145
    • Zinc finger and BTB domain containing 16
    • zinc finger and BTB domain containing protein 16
    • Zinc finger and BTB domain-containing protein 16
    • Zinc finger protein 145
    • Zinc finger protein 145 (Kruppel like expressed in promyelocytic leukemia)
    • Zinc finger protein PLZF
    • Znf145
    see all
  • FunctionProbable transcription factor. May play a role in myeloid maturation and in the development and/or maintenance of other differentiated tissues. Probable substrate-recognition component of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
  • Tissue specificityWithin the hematopoietic system, PLZF is expressed in bone marrow, early myeloid cell lines and peripheral blood mononuclear cells. Also expressed in the ovary, and at lower levels, in the kidney and lung.
  • PathwayProtein modification; protein ubiquitination.
  • Involvement in diseaseSkeletal defects, genital hypoplasia, and mental retardation
    A chromosomal aberration involving ZBTB16 may be a cause of acute promyelocytic leukemia (APL). Translocation t(11;17)(q32;q21) with RARA.
  • Sequence similaritiesBelongs to the krueppel C2H2-type zinc-finger protein family.
    Contains 1 BTB (POZ) domain.
    Contains 9 C2H2-type zinc fingers.
  • Cellular localizationNucleus.
  • Information by UniProt

References for Human Plzf peptide (ab39353)

ab39353 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab39353.
Please use the links above to contact us or submit feedback about this product.